Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China.

IF 7 1区医学 Q1 MEDICINE, GENERAL & INTERNAL

BMC Medicine Pub Date : 2024-10-15 DOI:10.1186/s12916-024-03694-4

Yanhua Song, Wei Shu, Yi Pei, Juan Du, Guihui Wu, Hua Wang, Fengling Mi, Fangchao Liu, Liping Ma, Li Xie, Zhongshun Kong, Xiaoguang Wu, Rongmei Liu, Hongmei Chen, Hua Li, Qiping Ge, Lihui Nie, Zizheng Lv, Xuerui Huang, Mingwu Li, Mingying Jiang, Xiaohong Chen, Qingshan Cai, Wei Chen, Yanmei Liu, Yanfang Miao, Yan Tang, Yu Chen, Shujun Geng, Quanying Zhou, Yuhong Liu, Yu Pang, Mengqiu Gao

引用次数: 0

查看原文本刊更多论文

更正：贝达喹啉、利奈唑胺、左氧氟沙星、氯法齐明和环丝氨酸化疗治疗利福平/耐多药结核病九个月：中国多中心、随机、开放标签非劣效性试验。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Medicine 医学-医学：内科

CiteScore

13.10

自引率

1.10%

发文量

435

审稿时长

4-8 weeks

期刊介绍： BMC Medicine is an open access, transparent peer-reviewed general medical journal. It is the flagship journal of the BMC series and publishes outstanding and influential research in various areas including clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional communities. In addition to research articles, the journal also publishes stimulating debates, reviews, unique forum articles, and concise tutorials. All articles published in BMC Medicine are included in various databases such as Biological Abstracts, BIOSIS, CAS, Citebase, Current contents, DOAJ, Embase, MEDLINE, PubMed, Science Citation Index Expanded, OAIster, SCImago, Scopus, SOCOLAR, and Zetoc.